Acumen Pharmaceuticals Inc (ABOS) Annual Income Statement (USD)
ABOS Quarterly Financials (USD)
Frequently Asked Questions About Acumen Pharmaceuticals Inc (ABOS) Stock
Acumen Pharmaceuticals Inc's (ABOS) last reported annual revenue was USD 0.00.
Acumen Pharmaceuticals Inc's (ABOS) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Acumen Pharmaceuticals Inc's(ABOS) is not profitable as of its last reported annual financials.
The net profit margin for Acumen Pharmaceuticals Inc's(ABOS) from its laster reported year is N/A
The return on equity (ROE) for Acumen Pharmaceuticals Inc's(ABOS) from its last reported annual financials is : -22.98%
The return on assets (ROA) for Acumen Pharmaceuticals Inc's(ABOS) from its last reported annual financials is : -15.08%
The return on invested capital (ROIC) for Acumen Pharmaceuticals Inc's(ABOS) from its last reported annual financials is : -25.31%
The Debt to Equity ratio for Acumen Pharmaceuticals Inc's(ABOS) from its last reported annual financials is : 10.24%
The dividend yield for Acumen Pharmaceuticals Inc's(ABOS) from its laster reported year is 0.00%
Acumen Pharmaceuticals Inc's(ABOS) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ABOS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
